Agreement of bone metastasis detection between bone scintigraphy and whole body-MRI in patient with hepatocellular carcinoma

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Observational

Source

TCTR

Registry ID

TCTR20150501001

Enrollment

Unknown

Registered

2015-05-01

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma Bone scintigraphy MRI

Interventions

Patient with Hepatocellular Carcinoma

Diagnostic

Hepatocellular Carcinoma

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Hepatocellular carcinoma patients 2. Suspected of bone metastasis

Exclusion criteria

Exclusion criteria: 1. Known bone metastasis 2. Known second primary cancer 3. Contraindication for bone scintigraphy 4. Contraindication for MRI

Design outcomes

Primary

Measure	Time frame
Cohen’s Kappa statistics Cross sectional Observation	—

Secondary

Measure	Time frame
none none none	—

Contacts

Public ContactTawatchai Chaiwatanarat

Chulalongkorn University

tawatchai.ch@chula.ac.th022564283

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Agreement of bone metastasis detection between bone scintigraphy and whole body&#45;MRI in patient with hepatocellular carcinoma